Dr. Shad completed his psychiatry residency at the University of Kansas School of Medicine-Wichita and a 2-year psychopharmacology fellowship in 1998. In 2000, he joined the Western Psychiatric Institute and Clinic at the University of Pittsburgh to advance his interest in neuroimaging research. Later Dr. Shad completed a Master of Science in Clinical Sciences (MSCS) at the University of Texas Southwestern, Dallas, and received an NIMH-sponsored K-23 mentored research award. In 2013, he moved to Southern Illinois University, Springfield, Illinois, as a residency program director. He continued his academic career at the Oregon Health & Sciences University, where he became a full academic professor in 2019. Dr. Shad is an adjunct professor at the University of Nevada, Las Vegas, and Touro University Nevada Osteopathic College of Medicine and a founding psychiatry residency program director in Las Vegas in 2023. Dr. Shad has received federal, investigator-initiated, and private research funding. Dr. Shad also received support for two investigator-initiated trials on the utility of pharmacogenomic algorithms in schizophrenia. Dr. Shad has received several teaching awards and has authored over one hundred peer-reviewed publications. He has presented at national and international meetings, including UN-sponsored psychopharmacology workshops and seminars outside the United States. Dr. Shad is also a distinguished fellow at the American Psychiatric Association.